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Abstract The objectives of this study are: (1) to under-
stand the importance of nutrition in normal growth; (2) to
review the methods of assessing nutritional status; (3) to
review the dietary requirements of normal children through-
out childhood, including protein, energy, vitamins and
minerals; (4) to review recommendations for the nutritional
requirements of children with chronic renal failure (CRF)
and on dialysis; (5) to review reports of spontaneous
nutritional intake in children with CRF and on dialysis;
(6) to review the epidemiology of nutritional disturbances
in renal disease, including height, weight and body
composition; (7) to review the pathological mechanisms
underlying poor appetite, abnormal metabolic rate and
endocrine disturbances in renal disease; (8) to review the
evidence for the benefit of dietetic input, dietary supple-
mentation, nasogastric and gastrostomy feeds and intra-
dialytic nutrition; (9) to review the effect of dialysis




The importance of nutrition in normal growth
Normal growth can be divided into four important phases:
prenatal, infantile, childhood and pubertal. Nutrition is
important at all phases of growth, but particularly so
during the infantile phase because the rate of growth is
higher than at any other time of life (other than prenatally)
and is less dependent on growth hormone (GH) than
during other phases. Rate of growth gradually decreases
from >25 cm/year at birth to an average of 18 cm/year at
age 1 year and 10 cm/year by the age of 2. Half of adult
height is achieved by the age of 2 years, so that
irrecoverable loss of growth potential can occur during
this phase. At birth, 170 kcal/day are stored in new tissue,
falling to 50–60 at 6 months, 30–40 by 1 year and 20–30
by the age of 2 years. During the childhood phase, growth
becomes more dependent on the GH/insulin-like growth
factor-1 (IGF-1) axis; growth rate decelerates continuously
until the pubertal phase. The pubertal phase results from
the coordination of GH and sex steroid production.
Together they have an anabolic effect on muscle mass,
bone mineralization and body proportions. It is another
phase of rapid growth so that nutrition can again modify
the genetic growth potential [1].
Methods of assessing nutritional status
Normal nutrition can be defined as maintenance of normal
growth and body composition. Although it is agreed that
nutritional assessment is important in chronic renal failure
(CRF), there is no single or easy definition or measure of
inadequate nutritional status: measurement of nutritional
parameters are complicated in CRF because of salt and
water imbalances and the potential inappropriateness of
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and may be delayed in puberty; it has been suggested that
it is more appropriate, therefore, to express measures
relative to height age (age at which the child’s height
would be the 50th centile) and/or pubertal stage. The
reader is referred to extensive and excellent reviews on this
subject [2, 3].
Anthropometric measures
The most commonly used assessment of nutrition is height
and weight, along with head circumference in younger
children, plotted on percentile charts. Anthropometric and
nutritional measures are usefully expressed as a score of the
number of standard deviations (SDs) from the mean for a
normal population of the same age [e.g. height or weight
SD score (HtSDS, WtSDS), also called z scores]. This
allows comparison with the normal population and helps
follow progress in the individual patient. However,
although a normal rate of growth can be considered to
represent adequate nutrition, weight loss and alterations in
body composition occur before height velocity is affected
[2], and poor growth can occur due to reasons other than
nutrition (see below).
Another way of expressing the relative weight and
height is the body mass index (BMI, Ht/Wt
2), which is
important because extremes are associated with increased
morbidity and mortality [4]. Because BMI varies consider-
ably throughout childhood, reaching a trough at 4–6 years
of age, it has been suggested that it should be calculated
according to height age [5]. It must be borne in mind that
BMI does not distinguish between fat mass and fat-free
mass (FFM) and an appropriate BMI for age (whether
height age or chronological age) does not necessarily
indicate ideal body composition; weight gain may be due
to the laying down of excess fat rather than a balance of fat
and lean tissue.
Skinfold thickness is a measure of subcutaneous fat and
mid-arm circumference (MAC) is a reflection of muscle
mass and may therefore be more useful in determining
body composition than the calculation of BMI alone.
Decreased values have been found in children with CRF
[6–9]. However, both are rather unreliable tools because
consistent measurements are difficult, values may not be
representative of visceral fat and fat or muscle mass,
oedema will influence values, regional fat and muscle
distribution may be different in CRF and values vary
according to age in normal children.
Dietary assessment
The paediatric renal dietician is crucial to the successful
management of nutrition in children with renal disease.
Monthly review has been recommended for under twos
on dialysis, and three- to four-monthly in those over that
age [10]; and six-monthly or one- to three monthly in
children with moderate and severe CRF, respectively [3].
The purpose is to prevent the development of malnutri-
tion. Children entirely dependent on enteral feeds may
need to be seen more often, particularly in infancy when
feed adjustments may be necessary as often as weekly.
Assessment of intake in children taking an oral diet can
depend on prospective dietary diaries, usually over 3
days, or retrospective recall. It has been estimated that 5.9
contacts per patient (in clinic or by phone) per month in
children <5 years of age and 3.1 in children >5 years of
age are necessary to successfully support families of
children on peritoneal dialysis (PD). This intensive input
resulted in improvement of HtSDS and WtSDS from
−1.2 and −1.32 to −1.14 and −0.73, respectively, over a
3-year period [11]. Protein intake can also be calculated
using well established formulae (protein catabolic rate,
nPCR [2]).
Serum albumin
Serum albumin has been identified as a surrogate marker
for nutritional status and morbidity/mortality in patients
with end-stage renal failure (ESRF). Patients <18 years
of age initiating dialysis with hypoalbuminemia are at a
higher risk for death: in 1,723 children each fall of
serum albumin by 1 g/dl at the start of dialysis was
associated with a 54% higher risk of death. This was
independent of other potential confounding variables
[12].
Although serum albumin may be a reflection of
nutrition, low levels may be due to haemodilution,
nephrotic syndrome or chronic infection/inflammation
[13]. To remove the effect of fluid overload, therefore, it
has been suggested that if practical, levels should be
checked post dialysis [14]. Chronic inflammation in itself
will lead to malnutrition [15]. Low serum albumin is more
common in children on PD: low levels were present in
35.9% of assays in 39 children on PD over a 2-year
period compared with none in 32 children on haemodial-
ysis (HD), even though protein intake (estimated by
nPCR) was similar, averaging 1.1 g/kg per day. Thus,
children maintained on PD are at greater risk of protein
malnutrition compared with peers treated with HD [16].
This may be due in part to losses in PD fluid: average
losses of free amino acids (AA) vary with transporter status
from 0.02 to 0.03 g/kg/day [17]. There is an inverse
correlation between body weight and surface area and
peritoneal protein loss, such that infants have nearly
twofold greater peritoneal protein losses per metre-square
body surface area than those weighing more than 50 kg.
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may contribute to permanent loss of growth potential [18].
Dual energy X-ray absorptiometry (DEXA) and other
methods
Awhole body DEXA scan can estimate fat mass, lean mass
and bone mineral density (BMD), but is affected by body
water content. Other methods include bioelectrical imped-
ance analysis (BIA) [19], total body potassium, densitom-
etry and in vivo neutron activation analysis, but these are
predominantly used as research tools [2].
Nutritional requirements for normal children
Recommended daily amounts (RDA) and recommended
intakes (RI) for energy, protein and nutrients vary between
countries. Regardless of the national dietary recommenda-
tions that are used it is important to consider that these are
estimates of requirements for normal healthy populations
of people and are not recommendations for absolute
intakes for individuals. They serve as a guide for the
energy and nutrients that an individual may require for
normal growth, maintenance, development and activity.
Requirements for any particular nutrient will differ
between individuals.
The United Kingdom dietary reference values (DRV)
[20] are for infants fed artificial formulas and for older in-
fants, children and adults consuming food. DRVs are not
set for breast-fed babies, as it is considered that human milk
provides the necessary amounts of nutrients. In some cases
the DRVs for infants aged up to 3 months who are formula-
fed are in excess of those which would be expected to
derive from breast milk; this is because of the different
bioavailability of some nutrients from breast and artificial
milk.
The DRV for energy intake is assumed to be normally
distributed and is expressed as the estimated average
requirement (EAR). For protein and other nutrients,
requirements are expressed as reference nutrient intakes
(RNI), set at 2 SDs above the average. Therefore, intakes of
protein and nutrients above this amount will almost
certainly be adequate for all individuals in a population.
For some nutrients where there is insufficient data to
establish DRVs with great confidence safe intakes are set—
a level or range of intake at which there is no risk of
deficiency.
Daily DRVs for energy, protein and some nutrients are
given in Table 1. If a diet for a normal child is adequate in
calcium, iron and vitamin C and the child is receiving
adequate energy from a mixed diet, then most other
nutrients are likely to be taken in adequate amounts.
Nutritional requirements for children with CRF,
on dialysis and post transplant
Energy
It is unlikely that energy requirements for children with
CRF are different from those of normal children, and
energy intakes below the EAR will contribute to growth
failure. Restoration of normal energy requirements to 100%
EAR allows for catch-up growth in children under 2 years
and shows some benefit in older children (see section on
Dietary supplements). If recurrent vomiting resulting from
abnormal gastric motility and delayed gastric emptying is
not treated, energy intake may need to be increased by up to
30% daily to replace lost feed and food in order to preserve
growth; once vomiting is controlled growth is maintained
on normal energy requirements [21]. To ensure an adequate
energy intake it is advisable to use the EAR for height age
if the child is below the 2nd centile for height.
There is no evidence that intakes for children on dialysis
should exceed those for normal children [10], though
dietary energy intake may need to be reduced for children
on PD to compensate for the energy derived from dialysate
glucose, estimated at 8–12 kcal/kg/day if there is excessive
weight gain [7, 22].
Post-transplant energy requirements should match those
of normal children, though care needs to be taken with
increased appetite in response to steroid administration. Up
to 13% of transplanted chidren become obese [23, 24]. A
reduction in energy intake is indicated where there is
excessiveweightgainandwillhelpcorrectanydyslipidaemia.
Protein
Protein intakes in CRF must provide at least 100% RNI if
protein is not to become the limiting factor for growth.
Inadequate protein will impact on body composition with a
preponderance of fat rather than lean tissue. Adequate
energy must be given to promote deposition of protein [25].
To ensure an adequate protein intake, it is advisable to use
the RNI for height age if the child is below the 2nd centile
for height.
In children undergoing PD, protein intake must provide
at least 100% RNI plus an allowance for both replacement
of transperitoneal losses and replacement of daily nitrogen
losses in order to achieve positive nitrogen balance [7, 18,
22]. There are few studies describing the optimal amount of
protein for children on PD and the existing data does not
include all age groups. Taking this into account, and the
wide variability in transperitoneal losses of protein, recom-
mended intakes for protein for populations of children on
PD may be considered generous. Routine assessment of
growth, albumin and urea levels will determine the required
Pediatr Nephrol (2007) 22:1689–1702 1691intake for the individual child. For chronic haemodialysis,
the Kidney Disease Outcomes Quality Initiative (K/DOQI)
recommends the RDA for age plus an increment of 0.4 g/
kg/day to achieve positive nitrogen balance [10]. This
recommendation is based on work done in adults on HD
who failed to maintain nitrogen balance on 1.1 g protein/kg/
day [26]. Published recommended intakes for the US and
the UK shown in Tables 2 and 3 are for populations and
may need adjustment for the individual.
Post-transplant protein requirements should match those
of normal children.
Vitamins and minerals
Little is known about the requirements of children with
CRF. It would be reasonable to give the RNI for vitamins,
minerals and micronutrients as for normal children, with the
exception of calcium, phosphate, magnesium, sodium and
potassium, which may be deranged and must be determined
for the individual child. UK RNIs are shown in Table 4.
*Vitamin A - care should be taken not to give excessive
amounts of vitamin A, as the resultant high serum levels
can lead to hypercalcaemia, anaemia and hyperlipidaemia
[29]. A common practice guideline is not to exceed 200%
of the RNI from the diet and/or supplements.
*Vitamin D - there is no need to achieve the RNI for
vitamin D, as it cannot be converted to the activated form
(as which it is usually supplemented). Recent recommen-
dations for adults are to assess 25 and 1, 25-vitamin D
levels and replace as needed, but there are no equivalent
recommendations for children.
*Folic acid - hyperhomocysteinaemia is an independent
risk factor for cardiovascular disease [30, 31]. Additional
folic acid may be given to effectively lower plasma
homocysteine levels. A common practice guideline is to
supplement when the glomerular filtration rate (GFR) is
<40 ml/min/1.73 m
2, but the doses used are arbitrary.
Infants: 250 μg/kg to maximum of 2.5 mg daily
Children 1–5 years: 2.5 mg daily
Children >5 years: 5 mg daily
In adults on PD, blood concentrations of some water
soluble vitamins (C, B6 and folic acid) are reported to be
low. This is due to a combination of inadequate intake,
increased transperitoneal losses and increased needs. In
children supplements of these vitamins have been given
with the result that blood concentrations have met or
exceeded normal values [32, 33]. Accordingly, based on
these authors’ recommendations and the RNIs above, the
following intakes are suggested [27]:
Vitamin C: 15 mg (infants)-60 mg (children) daily
Vitamin B6: 0.2 mg (infants)-1.5 mg (children) daily
Folate: 60 μg (infants)-400 μg (children) daily
These amounts may well be met from food, feeds and
nutritional supplements so it is important to assess the
dietary contribution before routinely giving medicinal
supplements. Whilst adequate vitamin C needs to be given
to offset dialysate losses excessive intakes should be
avoided, as the resulting elevated oxalate levels may lead
to cardiovascular complications [34]. If folic acid is given
to lower plasma homocysteine this will more than com-











Infants 0–0.5 2.2 2.6 2.9–3.0
0.6–1.0 1.6 2.0 2.3–2.4
Children 1–6 1.2 1.6 1.9–2.0
7–10 1.0 1.4 1.7–1.8
11–14 1.0 1.4 1.7–1.8
Males 15–18 0.9 1.3 1.4–1.5
Females 15–18 0.8 1.2 1.4–1.5
Table 1 UK dietary reference values for normal populations of children [20]( mo months, yr years)
Age EAR RNI RNI RNI RNI
Energy (kcal) Protein (g) Calcium (mmol) Iron (mg) Vitamin C (mg)
0–3m o 1 1 5 –100/kg 2.1/kg 13.1 1.7 25
4–6 mo 95/kg 1.6/kg 13.1 4.3 25
7–9 mo 95/kg 1.5/kg 13.1 7.8 25
10–12 mo 95/kg 1.5/kg 13.1 7.8 25
1–3 yr 95/kg 1.1/kg 8.8 6.9 30
4–6 yr 90/kg 1.1/kg 11.3 6.1 30
7–10 yr 1,970/day 28.3/day 13.8 8.7 30
Boy 11–14 yr 2,220/day 42.1/day 25.0 11.3 35
Girl 11–14 yr 1,845/day 41.2/day 20.0 14.8 35
Boy 15–18 yr 2,755/day 55.2/day 25.0 11.3 40
Girl 15–18 yr 2,110/day 45.0/day 20.0 14.8 40
1692 Pediatr Nephrol (2007) 22:1689–1702pensate for dialysate losses of folate. The K/DOQI
recommends that supplementation should be considered if
dietary intake alone does not meet or exceed the dietary
reference intake, if blood vitamin levels are below normal
values, or if there is clinical evidence of deficiency [10].
There are no reported specific micronutrient require-
ments for children on HD and post transplant and 100% of
the RNIs can be considered the goal for these children.
Calcium and phosphate
Control of phosphate, calcium and parathyroid hormone
(PTH) levels is necessary to prevent renal bone disease.
Dietary phosphate may need to be restricted when the GFR
falls below the normal range, and almost always when
below 50 ml/min/1.73 m
2. The following common practice
guidelines will help maintain serum phosphate within
acceptable reference ranges, although phosphate binders
may also be necessary.
Infants <10 kg: <400 mg daily
Children 10–20 kg: <600 mg daily
Children 20–40 kg: <800 mg daily
Children >40 kg: <1,000 mg daily
Iron, copper and zinc
Anaemia can be prevented by the prescription of iron
supplements and erythropoietin (rhuEPO). Advice to
increase dietary haem iron and reduce the inhibition of
non-haem iron absorption by: phytates in wholegrains and
legumes; polyphenols in tea, coffee and cocoa; calcium in
dairy products; and simultaneous administration of phos-
phate binders and antacids should be given. It may be
necesary to give intravenous iron if stores are low. Low
dietary intakes of copper and zinc are reported [35]i n
children on PD. The K/DOQI recommends the intake of
these to be monitored every 4–6 months and supplements
given if necessary [10].
Reports of spontaneous nutritional intake in children
with CRF
Several studies have demonstrated decreased spontaneous
intake in children with CRF. Four-day weighed dietary
records from 50 children with a GFR <65 ml/min/1.73 m
2
and 93 healthy children showed an energy intake 76–88%
of the RI in CRF patients and 90%–93% in controls.
Protein intake was 2.1–3.1 g/kg per day in controls and
1.6–2.7 g/kg per day in CRF patients, so that overall, the
energy intake was 10% and the protein intake 33% lower in
CRF patients than in healthy children [36]. Other studies
have shown low energy intake (87% RNI) but high protein/
energy ratio, protein (223%), carbohydrate (73%), fat
(110%), polyunsaturated (55%), monounsaturated (129%)
and saturated fatty acid (111%), with relative distribution of
calories of 15% from proteins, 48% from carbohydrates and
37% from lipids in 15 children with moderate CRF [14];
and RIs in 82 children with CRF were <86% for energy and
>161% for protein [12].
Although energy intake is low, it may be proportionate
to body weight: 4-day food records from 120 children with
CRF found an energy intake of 80% of RI for age,
decreasing with increasing age. However, this was in the
normal range when factored by body weight. The protein
intake was 153% of the RDA [37].
Intake deteriorates with severity of CRF: energy intakes
correlated negatively with GFR in 95 children with CRF,
and fell to 85% of EAR when the GFR was <25 ml/min/
1.73 m
2 [38]. Nitrogen balance studies have been per-
formed in 19 children on PD. Protein intake was 1.64 g/kg/
day (126% of the RDA), and the calorie intake reached
75% of RDA. Nitrogen losses were 0.205 g/kg/day, and
nitrogen balance was positive in three quarters of studies,
correlating with nitrogen and calorie intake [39].
Intake also decreases with time: 3-day semi-quantitative
dietary diaries in 51 children with a GFR <75 ml/min/
1.73 m
2 assessed over 2 years showed protein intake to
Table 4 Micronutrient guidelines for children with CRF [28]
Infants Children
Thiamin (mg) 0.2–0.3 0.5–1.0
Riboflavin (mg) 0.4 0.6–1.3
Niacin (mg) 3.8 8–18
Vitamin B6 (mg) 0.2–0.7 0.7–2.0
Vitamin B12 (μg) 0.3–0.5 0.5–1.5
Folic acid (μg)* 50–500 70–1000
Vitamin C (mg) 25 25–40
Vitamin A (μg)* 350 350–700
Vitamin D (μg)* 7–8.5 –
Zinc (mg) 4.0–5.0 5.0–9.5
Copper (μg) 0.2–0.3 0.3–1.0












Infants 0–3 mo 2.1 2.5 2.8–2.9
4–12 mo 1.5–1.6 1.9 2.2–2.3
Children 1–3 yr 1.1 1.5 1.8–1.9
4y r –puberty 1.0 1.4–1.5 1.7–1.9
Pubertal 1.0 1.3–1.4 1.6–1.8
Post–pubertal 0.9 1.2–1.3 1.4–1.5
Pediatr Nephrol (2007) 22:1689–1702 1693decrease by 0.4 g/kg per day, and calcium by −20% RNI
[40]. Energy and protein intake (energy more than protein),
all anthropometric measurements and plasma proteins and
AAs were low in 24 children on continuous ambulatory PD
(CAPD), particularly in those <10 years of age [13].
Low intakes of calcium [35–38], zinc [35, 37, 40, 41]
and vitamins [37, 40, 42] are also reported.
The epidemiology of nutritional disturbances in renal
disease, including height, weight and body composition
Height and weight
It is during the infantile phase of growth that the most
significant loss of height potential can occur, but also it is
the phase during which there is the greatest potential for
catch-up with nutritional intervention. Many infants with
CRF are already growth-retarded by the time they are first
seen in a paediatric nephrology service: a loss of HtSDS
from birth of −1.68 SD (up to −5 SD/year) has been
reported [43]. Approximately one-third of the reduction in
height occurs during foetal life and one-third during the
first 3 months, accompanied by a similar decline in head
circumference [44–46]. Mean HtSDS below the lower limit
of normal has been reported in most studies [43–46].
However, catch-up can occur, even on dialysis [47–49].
Poor nutritional status is associated with starting PD at a
younger age [50]. Interestingly, infants who grew well
continued with catch-up in early childhood [43, 47].
During the childhood phase, growth in CRF usually
parallels the centiles but without catch-up [43, 46]. The
North American Pediatric Renal Transplant Cooperative
Study (NAPRTCS) CRF database (<20 years of age, GFR
<75 ml/min/1.73 m
2) has shown a mean HtSDS that has
changed little since 1996 when it was −1.5 in 1,725
patients, to −1.4 (one third >−1.88) in 3,863 patients in
1998 and −1.4 in 4,666 patients in 2001 [51–53]. European
study group data on 321 children aged 1–10 years with
congenital CRF reported a mean HtSDS of −2.37.
Increasing severity of CRF adversely affects growth: when
the patients were divided into those with a GFR greater or
less than 25 ml/min/1.73 m
2, the HtSDS was −1.65 and
−2.79, respectively [44]. Reports of growth on dialysis vary
from improvement [54], to no change [55] to declining
HtSDS [56], with a worsening of nutritional status in
children dialysed for more than a year [50].
The pubertal phase of rapid growth is another period
when loss of height potential can occur. Early studies
demonstrated that puberty was delayed, with an irreversible
decline in height SDS, particularly in patients on dialysis
[57, 58]. However, others have reported normal pubertal
progression and growth [43, 46, 59].
Body composition
Children with CRF and short stature are significantly
protein-depleted for age, although not for height: 17
patients, mean age 12.9 years had total body nitrogen
(TBN) and TBN/height of 54% and 63%, respectively,
when predicted from age, but 100% when predicted from
height. Energy and protein intakes were 65% and 172% of
RDA, respectively. This suggests that chronic energy
deficiency may contribute to impaired protein deposition
which, in turn, may be important in the pathogenesis of
growth failure in CRF [25].
It has been suggested that the ratio of the length of trunk
to limb is low in CRF, suggesting a disproportionately
greater effect of disease and/or treatment on spinal growth
[60] although not all have found this [61].
BIA in children starting PD showed an improvement of
hydration and nutrition after 6 months, although levels
remained below normal, suggesting that introduction of
dialysis should not be left until malnutrition has developed
[62, 63]. DEXA studies of 20 PD patients receiving the
RDA for energy and a daily protein intake of 144.3% and
129.9% RI at months one and six showed an increase in
BMD, bone mineral content (BMC) and FFM. However,
the daily protein intake showed a negative correlation with
these parameters and also plasma bicarbonate, suggesting
that a high protein intake may negatively affect bone min-
eralization and FFM by its effect on acid-base status [64].
Disturbances in plasma and intracellular AAs have been
found in CRF. Muscle isoleucine and valine levels and the
valine/glycine ratio were low in children with CRF who
were short but had no other signs of malnutrition (normal
skinfold thickness, MAC and serum proteins) [65]. Levels
have been studied in ten children on CAPD. Although
plasma levels of essential AAs (EAAs) were low, only
muscle intracellular leucine and valine were low, whereas
both plasma and intracellular levels of some non-essential
AAs were high. No correlations were found between
plasma and muscle AAs and indicators of nutritional status,
except muscle branched-chain AA levels with BMI [66].
The pathological mechanisms underlying poor appetite,
abnormal metabolic rate and endocrine disturbances
in renal disease
Poor appetite is common in children with CRF and may in
part be due to abnormal taste sensation [67]. Appetite is
also affected by cytokines, and their roles in CRF, along
with their effect on metabolic rate, have been extensively
and excellently reviewed [68, 69]. Malnutrition may be an
inappropriate term in CRF because it infers that dietary
replacement would be curative (which is not always the
1694 Pediatr Nephrol (2007) 22:1689–1702case in CRF), and the term cachexia, which implies
replacement of muscle with fat and declining plasma
proteins, may be more appropriate [68, 69]. Cachexia may
result not only from anorexia but also from acidosis and
inflammation (which are common in CRF), which cause
elevated levels of cytokines such as leptin, TNF-α, IL-1
and IL-6. These act through the hypothalamus to affect
appetite and metabolic rate and maintain the constancy of
fat stores.
Leptin is produced by adipocytes and is probably the
most important cytokine involved in this process. When
body fat falls, levels of leptin decline and the brain
responds by increasing appetite and metabolic efficiency;
in contrast, when leptin levels rise, food intake is decreased
and metabolic rate increases. However, leptin is excreted by
the kidney and not cleared by dialysis, so levels can be
paradoxically high in malnourished patients, contributing
further to decreased food intake and increased metabolic
rate. Serum leptin levels were >95th percentile in 45% of
134 children with varying severity of CRF, and correlated
positively with their percentage body fat and GFR and
negatively with spontaneous energy intake [70]. Leptin
levels also correlate with CRP, a marker of inflammation,
and with insulin resistance [67, 69]. Leptin signalling in the
brain occurs through the hypothalamic melanocortin recep-
tors, and may offer a new area for therapeutic intervention
in the cachexia of CRF. The part played by the short-term
regulators of satiety, such as ghrelin (which stimulates
appetite), is not yet fully understood [68, 69].
Abnormalities of the GH/IGF-1 axis occur in CRF.
Whether they are primarily due to CRF itself or secondary
to malnutrition is controversial [71, 72]. GH levels are
normal to high and IGF-1 levels are low in both CRF and
malnutrition [73]. IGF-1 decreases according to nutritional
status in children on HD [71]. Leptin levels correlate
positively with IGF-1 and negatively with GH in children
with starvation [73]. However, in CRF this relationship is
disrupted: in 17 children on HD with energy and protein
intakes of 40–70 kcal/kg per day and 1–1.54 g/kg per day,
respectively, who had reduced anthropometric measure-
ments, although IGF-I levels were low, leptin levels were
high [74].
Evidence for the benefit of dietetic input, dietary
supplementation, nasogastric and gastrostomy
feeds and intradialytic feeding
There are very few controlled trials, so recommendations
are based on the evidence available. Some, but not all,
reports have been able to establish a relationship between
nutritional intake and growth. Growth velocity correlated
positively with energy intake in 17 children with CRF [75],
and with energy but not protein intake in 15 children on
CAPD [76]. Growth velocity was inversely correlated with
dietary protein intake and positively correlated with caloric
intake both before the initiation of rhGH therapy and after
the first year of treatment in 31 children on dialysis [77].
The advantage of input from a dietitian has been specifi-
cally demonstrated in two studies [11, 40], but it is likely
that in all studies dietetic input was necessary.
Dietary supplements
Because of the importance of nutrition in the first two years
of life it might be expected that enteral nutrition would be
most effective at this age. Most studies have therefore
concentrated on this age group, and there is evidence to
show that nutritional supplementation is of benefit. Eight
studies have demonstrated an improvement in growth [21,
47, 78–83], three showed an initial decline followed by
stabilisation [84–86], three showed no effect on growth [11,
87, 88] and one showed a decline in HtSDS [89]. All but
one study [86] used feeds administered by nasogastric or
gastrostomy tubes and aim for at least the EAR for energy
and RNI for protein, with a protein supplement for dialysis.
An early study of nasogastric feeding in 14 children
weighing <10 kg demonstrated a benefit on HtSDS and
WtSDS in 11 [78]. Twenty-six children aged <2 years with
a GFR <26 ml/min/1.73 m
2 were treated with a whey-based
infant formula (supplemented with fat and/or carbohydrate)
which provided 100% of the RNI for protein for Ht age and
100% of the EAR for energy for chronological age. HtSDS
increased from −2.9 to −2.1 over 2 years [21]. A similar
feed resulted in improvement in HtSDS from −2.34 at 6
months of age to −1.93 at 2 years in 24 infants with a GFR
<20 ml/min/1.73 m
2, and from −2.17 to −1.24 in 13 infants
on dialysis over a similar time-frame, although a protein
supplement for dialysis was included [47]. A further study
from the same centre showed an increase in HtSDS from
−1.8 to −0.8 at 2 years in 20 infants on PD [79]. Three
studies, each reporting the results of nasogastric feeding in
three young children with CRF, have shown benefit in eight
out of the nine children [80–82]. It is important not to
restrict the salt and water content of the diet in the salt-
wasting polyuric infant: a feed providing just over the RDA
for calories and protein diluted to 0.3–0.5 kcal/ml with
additional 2–4 mEq of sodium/100 ml in 24 infants resulted
in improvement of HtSDS by 1.37 SD at 1 year and 1.82
SD at 2 years [83].
Three studies have shown an initial decline followed by
normalisation of growth. Twelve infants with CRF dropped
to a HtSDS of −2 by 12 months of age and then stabilised
at that level [84]. Decline in HtSDS was arrested in eight
children <2.5 years of age after starting gastrostomy feeds
[85] and stabilised after 3 months in the only study using
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[86]. In three studies, enteral feeds made no impact on
growth: there was no change in infants with CRF [87], HD
[88]o rP D[ 11]. In one study, a decline in HtSDS occurred
in 82 children <2 years of age at the start of dialysis [89].
Whether supplemental feeds benefit children over 2
years of age has been challenged [90]. Six studies have
included older children [21, 80, 81, 85, 89, 91]. Of these
there was an improvement in growth in three [80, 81, 91].
Dietary advice and supplements of glucose polymer and
vitamins (as Ketovite) were given to 65 children aged 2–16
years with a GFR <75 ml/min/1.73 m
2 if their EAR and
RNI, respectively, fell below 80% as assessed by annual
3-day dietary diaries. Mean HtSDS was maintained in those
with a GFR of 25–75 and significantly increased in children
with a GFR <25 ml/min/1.73 m
2. There was an increase in
HtSDS and/or BMI SDS in all the patients on supplements,
and change in energy intake correlated with change in
HtSDS in those with a GFR <25 ml/min/1.73 m
2 [91].
Three children with a GFR of 20–25 ml/min/1.73 m
2 fed
overnight by nasogastric tube for 11–16 months with
increasing amounts until weight gain occurred improved
their HtSDS [81], as did three children with CRF over the
course of a year [80]. Two studies have shown no change in
HtSDS. Nine children aged 2–5 years, treated with a whole
protein enteral feed supplemented with fat and/or carbohy-
drate showed no change in HtSDS (−2.3 to −2.0) [21], as
did seven children in given gastrostomy feeds [85]. One
study has demonstrated an ongoing decline in HtSDS in
children aged 2–5 years at the start of dialysis, 14 of whom
were given supplements and 20 not [89].
Complications of gastrostomy are uncommon, but
include gastro-colic fistulae, paraoesophageal herniae and,
in children on PD, post-surgical peritonitis and an increased
risk of exit site infection and dialysis catheter removal from
infection, a risk that might be reduced if open rather than
percutaneous surgery is used [92, 93]. After removal the
track usually closes spontaneously [94]. There have been
concerns that enteral tube feeding precludes the develop-
ment of normal feeding behaviour [95]. However, other
studies have shown that, despite long term nasogastric or
gastrostomy feeding, oral feeding is resumed in the
majority of children after successful transplantation [21,
96]. Positive reinforcement at feeding times using behav-
ioural therapy techniques allowed five infants who had PD
and nasogastric tube feeding initiated in the first month of
life, and who showed persistent food refusal, to convert to
oral feeding [97]. Our impression is that spontaneous oral
intake increases with long-term tube feeding; indeed, over a
period of 31 months energy intake from the feed did not
increase, implying that oral intake had improved over this
time to support the demonstrated growth [21]. Reports of
the use of Nissen fundoplication are principally from one
group [21, 47, 54, 79, 88, 92], making assessment of its
effect difficult, although results of growth from this centre
are good.
Essential aminoacid (EAA) supplements
Serum EAAs, carnitine and total protein levels have been
demonstrated to be low in CRF, particularly in patients on
PD [98]. It has been suggested, therefore, that a low protein
diet supplemented with EAAs might benefit growth by
ensuring adequate AA intake without protein toxicity.
However, results have been inconclusive. No improvement
in growth was seen in seven children with severe CRF who
were given half the protein RDA for height age as EAAs
for 6–8 months [99]. Ten children with CRF managed for 3
years using a strict low protein diet supplemented by a
mixture of the keto and amino forms of the EAAs and
histidine showed a significant increase in height and weight
velocity [100]. HtSDS improved from −1.93 to −1.37 over
30 months in 20 patients with a GFR <50 ml/min/1.73 m
2
on a diet of 0.6 g/kg of protein supplemented with
ketoacids [101]. Ten children on HD given AA supple-
mentation (0.25 g/kg body weight i.v.) with and without
carnitine (25 mg/kg body weight i.v.) had no overall
improvement in AA levels [102].
Amino acid-containing peritoneal dialysis solutions
Excessive glucose absorption and dialysate AA and protein
losses contribute to malnutrition in children on PD. It has
been suggested, therefore, that using an AA dialysate might
both decrease glucose load and replace AA losses. AAs are
absorbed in proportion to the concentration difference
between dialysate and plasma; after a 1% AA exchange in
seven children on CAPD, the rise in plasma levels of AAs
correlated with the ratio of the amount of AA in the bag to
the basal plasma concentration. The amount of AA absorbed
was 66% after 1 h, and 86% after 4 h and 6 h [103, 104].
However, there is no evidence for any long-term
nutritional benefit: eight children on CAPD who had a first
morning exchange of 1% AA dialysate instead of dextrose
for 12–18 months had no improvement in any plasma or
anthropometric parameter of nutrition; plasma urea in-
creased. Plasma EAAs, which had been low, improved
but the intracellular pool of free AAs, measured in
polymorphonuclear leucocytes did not improve [105].
Two randomised prospective cross-over studies of 3 months
AA or dextrose dialysate for three months have been
performed, both in seven growth-retarded children either on
CAPD [106] or continuous cycling PD (CCPD) [107]. In
the children on CAPD there was no nutritional benefit from
the AA dialysis [106]. The children on CCPD received
dextrose dialysate overnight, plus a single daytime dwell of
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and protein intake improved and total body nitrogen
increased in half the children during AA dialysis. However,
total plasma protein and albumin did not change and fasting
AAs after 3 months of AA dialysis were comparable to
baseline; plasma urea concentrations were higher [107].
High plasma urea may be due to inadequate protein
synthesis in the absence of glucose. Ten children underwent
overnight CCPD using a 3:1 ratio of glucose to AA
solutions simultaneously during the night. Glucose absorp-
tion was 33.7% and AA absorption was 55.2% of the
infused amount, and although plasma AA levels were high
for the entire ambulatory PD (APD) treatment the plasma
urea levels did not increase suggesting that the AAs were
being used for protein synthesis with this regimen [108].
Disadvantages compared with glucose include cost, and
reports of fluid removal are variable. However, equal
amounts of urea and creatinine are removed, normoglycae-
mia is maintained and there are no reported adverse clinical
or biochemical effects, other than a slight increase in
plasma urea [106, 107, 109].
Intradialytic parenteral nutrition (IDPN)
There are only four studies of IDPN during HD in children
so it is difficult to draw conclusions about its effectiveness.
Losses of AAs occur into the dialysate during HD and
depend on their plasma concentrations and molecular
weights. AAs were added to the dialysate of three children
in increasing concentrations. Plasma nonessential AAs were
not affected, but EAAs improved [110]. Four malnourished
children on HD were given IDPN as AAs (8.5% solution),
glucose (10% to 15% dextrose), and 20% fat emulsion at
every dialysis session (three times a week) for 7–12 weeks.
Oral intake improved and, although weight did not improve
during treatment, it did so subsequently. Albumin did not
change [111]. The weights of three children improved after
6 weeks of IDPN; again, albumin did not improve [112].
Nine patients who on HD had a >10% weight loss and were
<90th percentile of ideal body weight received thrice
weekly IDPN. In six, BMI increased in the first 5 months
and PCR increased, whereas serum albumin did not change;
those who did not gain weight were considered to have
psychosocial causes for their malnutrition [113].
Nutritional causes of poor growth not related to energy
and protein
Sodium
Requirements for sodium vary according to the type of
renal disease. Congenital structural abnormalities often
result in an obligatory urinary loss of salt and water. Such
children may become chronically salt- and water-depleted
and need sodium supplementation and free access to water
as salt wasting impairs growth [83]. On the other hand,
children with glomerular disease need to restrict their
sodium intake. Young children on PD may need sodium
supplementation as considerable sodium losses can occur in
dialysate.
Acidosis
Acidosis is associated with a catabolic state, suggesting
that acidosis-related protein wasting could contribute to
growth retardation [114, 115]. Correction of acidosis
improves serum albumin, catabolic rate and growth [83,
116, 117].
Anaemia
Anaemia is a well recognised cause of poor appetite.
However, studies that include blinded, placebo-controlled
trials have found that despite subjective increases in
appetite, there were no consistent improvements in dietary
intake or anthropometric measures observed during rhuEPO
treatment [118–122].
Vitamin D
The dose of calcitriol prescribed to control hyperparathy-
roidism must be balanced against its potential to depress the
activity of chondrocytes causing adynamic bone disease.
Large doses impair growth, even if intermittent [123, 124],
but the frequency of administration does not affect growth
if small doses are used [125, 126].
Growth hormone
There may be cases when, despite at least 6 months of
adequate nutrition, growth continues to be poor. GH may be
offered in these circumstances.
The effect of dialysis adequacy on nutrition
Several studies have looked to see whether increasing
dialysis dose benefits appetite, protein intake, nutrition and
growth. Twenty-one children on CCPD showed an im-
provement in HtSDS when aiming for a Kt/V of >2 and a
creatinine clearance of >60 l/week/1.73 m
2 compared with
1.7 and 40 l/week/1.73 m
2 [127].
However, in some, but not all studies, there would
appear to be a ceiling above which no further benefit
occurs. The nPCR and serum albumin were assessed
according to Kt/V in 15 patients on HD. Serum albumin
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a Kt/V <1.3, but increasing over 1.6 did not improve
nPCR further, suggesting that although adequate dialysis
needs to be achieved in order to ensure good protein
intake, high dialysis doses are of no further benefit [128].
However, in 12 children taking 90.6% and 155.9% of their
requirements for energy and protein, respectively, and
receiving HD with a Kt/V of 2.00 and a urea reduction
ratio of 84.7%, there was an improvement in HtSDS of
+0.31 SD/year and pubertal growth was normal, suggest-
ing that for HD, increasing dialysis dose does improve
growth [129].
In PD, but not HD, there was an inverse relationship
between albumin level and Kt/V, suggesting that increasing
PD dose may reach a point of no further benefit due to
increasing albumin losses in PD fluid [130]. PD causes an
influx of glucose which can contribute to obesity. High
transporter status was associated negatively with HtSDS
and positively with BMI SDS in 51 children on PD.
Large dialysate volumes also affected BMISDS [131].
Improving dialysis dose can be achieved by the ad-
dition of an icodextrin daytime dwell to overnight PD.
A cross-over study in eight children of overnight PD
with or without addition of a daytime dwell with
1,100 ml/m
2 icodextrin for a week showed an improve-
ment in weekly dialysis creatinine clearance from 35 to
65 l/week/1.73 m
2 and Kt/V from 1.99 to 2.54. However,
protein and calorie intake did not improve and peritoneal
albumin loss and serum albumin did not change, but there
was increased loss of AAs, although plasma AA levels did
not change [132].
Residual renal function (RRF) has an important positive
effect on clearance and growth. Mean HtSDS improved
from −1.78 to −1.64 over a year of PD in 12 patients with
RRF, but declined from −1.37 to −1.90 in 12 patients
without. Weekly Kt/V was not different, and only the native
kidney Kt/V and creatinine clearance correlated with
growth, suggesting that clearance obtained by PD cannot
be equated with that obtained by native kidneys [133].
Eleven of 20 patients on PD with a minimum total Kt/Vof
2.1, daily protein intake of 3.25 g/kg/day and HtSDS of
−2.3 improved their HtSDS by 0.55, while in nine it
declined by −0.50. Variables affecting growth were nitro-
gen balance and residual Kt/V [134].
The role of nutrition in the outcome of children
with CRF
Malnutrition is associated with increased mortality. The
association with plasma albumin levels has already been
discussed [12]. Of 2,306 children, those with a HtSDS less
than −2.5 at the start of dialysis had a twofold higher risk of
death [135]. In 1,949 children with ESRF, each decrease in
height by 1 SD was associated with a 14% increase in risk
for death, and there was a U-shaped association between
BMI and death [4]. Part of this may be due to an increased
risk of infection in malnourished patients [136].
In conclusion, commencement of careful nutritional
support early in the course of disease may improve not only
growth but also mortality in children of all ages with CRF.
Multiple choice questions
(Answers appear following the reference list)
For each question answer true or false:
1. During the phases of growth
a) Rate of growth is highest during prenatal life
b) 50% of final height is achieved by the age of 2
years
c) The infantile phase of growth is principally
dependent on growth hormone
d) Growth rate stays the same throughout the child-
hood phase of growth
e) A pubertal growth spurt can occur without the
development of secondary sexual characteristics
2. Assessment of nutritional status in CRF and on dialysis
a) It may be more appropriate to express measures of
growth according to height age rather than chrono-
logical age
b) The height standard deviation score (HtSDS) is the
number of standard deviations from the mean for a
normal population of the same age and sex
c) The BMI is the Ht/Wt
2 and indicates the proportion
of fat mass to fat free mass
d) Low serum albumin is always an indication of
malnutrition
e) Peritonealprotein losses in dialysate are twofold
greater in relation to body surface area in infants
than in those >50 kg in weight
3. Nutritional requirements
a) The estimated protein requirement for a normal
healthy 30-week-old girl weighing 6.0 kg (0.4th
centile) and 59.0 cm in length (<0.4th centile) is
>2.1 g/kg/day
b) Her estimated energy requirement is 150 cal/kg/day
c) The prescribed dietary protein intake for the same
child on PD would be 2.8–3.0 g/kg/day
d) Children with CRF or on dialysis need a calorie
intake that exceeds the EAR for height age
e) Supplements of vitamin A are necessary in children
on dialysis
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a) Abnormal taste sensation can occur in CRF and on
dialysis
b) Leptin is produced by adipocytes and levels are
high in CRF and on dialysis
c) High leptin levels cause an increase in food intake
and metabolic rate
d) GH levels are normal or high and IGF-1 levels are
low in CRF
e) GH levels are normal or high and IGF-1 levels are
low in malnutrition
5. Dietary supplementation
a) Salt restriction is important in all children with
CRF
b) Nutritional supplementation has not been shown to
benefit children over two years of age
c) Increasing dialysis dose in PD may increase
peritoneal dialysate protein losses and contribute
to obesity
d) Sodium supplementation may be necessary in
children on PD
e) Gastrostomy placement is preferable before PD
commences
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